Abstract |
A 75-year-old woman with Glanzmann's thrombasthenia was admitted because of persistent melaena. Endoscopic examination showed multiple angiodysplastic lesions, with active bleeding in small and large bowel. Electro-coagulation of some lesions, octreotide, conjugated oestrogens and selective embolization of jejunal vessels did not change transfusion requirements. After 8 month-transfusions, ethinylestradiol + norethisterone in association with octreotide was started, leading to no transfusion over the following 9 months. Bleeding recurred after withdrawing octreotide and substituting ethinylestradiol + norgestrel for the ethinylestradiol + norethisterone combination. Re-introduction of octreotide did not improve bleeding; however, a reduction of transfusion requirement was observed when the ethinylestradiol + norethisterone pill was re-administered. The association of octreotide and of an oestrogen- progesterone combination was helpful in the difficult management of recurrent bleeding in this patient with diffuse gastrointestinal vascular abnormalities and a severe condition predisposing to bleeding.
|
Authors | A Coppola, V De Stefano, A Tufano, G Nardone, A Amoriello, A M Cerbone, G Di Minno |
Journal | Journal of internal medicine
(J Intern Med)
Vol. 252
Issue 3
Pg. 271-5
(Sep 2002)
ISSN: 0954-6820 [Print] England |
PMID | 12270009
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Estradiol Congeners
- Gastrointestinal Agents
- Hemostatics
- Progesterone Congeners
- Ethinyl Estradiol
- Octreotide
- Norethindrone
|
Topics |
- Aged
- Anemia
(etiology, therapy)
- Angiodysplasia
(complications, diagnosis, therapy)
- Blood Transfusion
- Drug Therapy, Combination
- Electrocoagulation
- Estradiol Congeners
(administration & dosage)
- Ethinyl Estradiol
(administration & dosage)
- Female
- Gastrointestinal Agents
(administration & dosage)
- Hemostatics
(administration & dosage)
- Humans
- Intestinal Diseases
(complications, therapy)
- Melena
(diagnosis, etiology, therapy)
- Norethindrone
(administration & dosage)
- Octreotide
(administration & dosage)
- Progesterone Congeners
(administration & dosage)
- Recurrence
- Thrombasthenia
(complications, drug therapy)
- Treatment Outcome
|